Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
September 01, 2020 08:30 ET
|
Jounce Therapeutics, Inc.
– Gilead Will Have Exclusive Rights to Develop and Commercialize Anti-CCR8 Antibody – – Gilead to Make $85 Million Upfront Payment and $35 Million Equity Investment – FOSTER CITY, Calif. and...
REPEAT -- Red White & Bloom Brands Inc. Signs Agreement With High Times, Securing Exclusive Licensing Rights for High Times Branded Locations and Product Brands for Michigan, Illinois and Florida
June 05, 2020 12:57 ET
|
Red White & Bloom Brands Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR DISSEMINATION IN THE UNITED STATES TORONTO, June 05, 2020 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: TDRYD) (“RWB” or...
Red White & Bloom Brands Inc. Signs Agreement With High Times, Securing Exclusive Licensing Rights for High Times Branded Locations and Product Brands for Michigan, Illinois and Florida
June 05, 2020 07:00 ET
|
Red White & Bloom Brands Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR DISSEMINATION IN THE UNITED STATES TORONTO, June 05, 2020 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc....
American International Holdings Corp Executes Exclusive License Agreement to Establish Novopelle Locations Worldwide
July 05, 2019 09:00 ET
|
American International Holdings Corp.
HOUSTON, TX, July 05, 2019 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTC: AMIH, or the “Company”) is pleased to announce that it has entered into an exclusive, irrevocable license...